A retrospective review was undertaken of the medical records of 270 pa
tients with carcinoma of the glottic larynx. Patients were staged path
ologically, and clinical pathologic correlates were made with outcome.
In 92 patients with early glottic cancer, the 2-year rate of no evide
nce of disease for T1 was 98%, and for T2, 84%. Vertical partial laryn
gectomy resulted in voice preservation in 89%. Patients treated for ad
vanced (T3 or T4) glottic carcinoma underwent total laryngectomy with
or without neck dissection. Cervical nodes were involved in 22% of T3
and 41% of T4 patients at the time of treatment Survival with no evide
nce of disease was chiefly determined by the development of regional r
ecurrence, distant metastasis, and new primary cancer. Distant metasta
sis was associated with extracapsular spread (p = .003). Patients trea
ted for T4 glottic carcinoma with neck dissection had improved surviva
l compared with patients with laryngectomy alone (p = .006). Improved
survival must be aimed at regional control, prevention, and management
of distant metastasis and new primary carcinoma.